409201000: Pegvisomant (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Substance with receptor antagonist mechanism of action (substance)\Growth hormone receptor antagonist\Pegvisomant (substance)

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Substituted amide (substance)\Peptide\Pegvisomant (substance)

\Organic compound\Organic nitrogen compound\Amide and/or amide derivative (substance)\Substituted amide (substance)\Peptide\Pegvisomant (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2004. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

2464652010 Pegvisomant (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

2471011017 Pegvisomant en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

3198661000005119 pegvisomant da Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) Danish module (core metadata concept)

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Pegvisomant (substance)	Is a	Hormone antagonist	false	Inferred relationship	Some
Pegvisomant (substance)	Is a	syntetisk antihormon	false	Inferred relationship	Some
Pegvisomant (substance)	Is a	Peptide hormone receptor antagonist	false	Inferred relationship	Some
Pegvisomant (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Peptide hormone receptor antagonist (disposition)	false	Inferred relationship	Some
Pegvisomant (substance)	Is a	Peptide	true	Inferred relationship	Some
Pegvisomant (substance)	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Growth hormone receptor antagonist (disposition)	true	Inferred relationship	Some
Pegvisomant (substance)	Is a	Growth hormone receptor antagonist	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Pegvisomant 20 mg powder for solution for injection vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pegvisomant (substance)	Inferred relationship	Some
Pegvisomant 30mg powder for injection solution vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pegvisomant (substance)	Inferred relationship	Some
Product containing pegvisomant (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Pegvisomant (substance)	Inferred relationship	Some	1
Product containing precisely pegvisomant 10 milligram/1 vial powder for conventional release solution for injection (clinical drug)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pegvisomant (substance)	Inferred relationship	Some
Pegvisomant 15 mg powder for solution for injection vial	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	False	Pegvisomant (substance)	Inferred relationship	Some
Pegvisomant only product	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Pegvisomant (substance)	Inferred relationship	Some	1
Pegvisomant 15 mg powder for solution for injection vial	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Pegvisomant (substance)	Inferred relationship	Some	1
Pegvisomant 15 mg powder for solution for injection vial	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Pegvisomant (substance)	Inferred relationship	Some	1
Product containing precisely pegvisomant 10 milligram/1 vial powder for conventional release solution for injection (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Pegvisomant (substance)	Inferred relationship	Some	1
Product containing precisely pegvisomant 10 milligram/1 vial powder for conventional release solution for injection (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Pegvisomant (substance)	Inferred relationship	Some	1
Pegvisomant 20 mg powder for solution for injection vial	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Pegvisomant (substance)	Inferred relationship	Some	1
Pegvisomant 20 mg powder for solution for injection vial	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Pegvisomant (substance)	Inferred relationship	Some	1
Product containing pegvisomant in parenteral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Pegvisomant (substance)	Inferred relationship	Some	1
Product containing only pegvisomant in parenteral dose form (medicinal product form)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Pegvisomant (substance)	Inferred relationship	Some	1
Product containing precisely pegvisomant 30 milligram/1 vial powder for conventional release solution for injection (clinical drug)	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Pegvisomant (substance)	Inferred relationship	Some	1
Product containing precisely pegvisomant 30 milligram/1 vial powder for conventional release solution for injection (clinical drug)	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Pegvisomant (substance)	Inferred relationship	Some	1

This concept is not in any reference sets